Cao, Wei

Gracell Biotechnologies, Ltd, Shanghai, China

1 paper on CoChatORCID 0000-0001-9163-5711

Most cited papers

Verified
Updated results of a phase I, open-label study of BCMA/CD19 dual-targeting fast CAR-T GC012F for patients with relapsed/refractory multiple myeloma (RRMM).
Du, J., Fu, W.-J., Jiang, H., Dong, B., Gao, L., Liu, L., Ge, J., He, A., Li, L., Lu, J., et al. (2023) · Journal of Clinical Oncology
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 35

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free